UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000032480 |
|---|---|
| Receipt number | R000037037 |
| Scientific Title | Valuable screening test to determine the cause of uveitis using sample like aqueous humor |
| Date of disclosure of the study information | 2018/12/01 |
| Last modified on | 2024/05/10 13:48:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Valuable screening test to determine the cause of uveitis using sample like aqueous humor
Acronym
Screening for sample like aqueous humor
Scientific Title
Valuable screening test to determine the cause of uveitis using sample like aqueous humor
Scientific Title:Acronym
Screening for sample like aqueous humor
Region
| Japan |
Condition
Condition
uveitis
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the pathogen and the cytokine in sample like aqueous humor from uveitis patients qualitatively and quantitatively, comparing to control from cataract patients
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Levels of DNA of pathogen and cytokine in sample like aqueous humor from patients that may induce or be relevant to uveitis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
uveitis
Key exclusion criteria
none
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Masahiro |
| Middle name | |
| Last name | Zako |
Organization
Asai hospital
Division name
Department of Ophthalmology
Zip code
4890866
Address
178-1 Yakata-cho, Seto, Aichi
TEL
0561843111
mzako@aol.com
Public contact
Name of contact person
| 1st name | Masahiro |
| Middle name | |
| Last name | Zako |
Organization
Asai hospital
Division name
Department of Ophthalmology
Zip code
4890866
Address
178-1 Yakata-cho, Seto, Aichi
TEL
0561843111
Homepage URL
mzako@aol.com
Sponsor or person
Institute
Asai hospital
Institute
Department
Personal name
Funding Source
Organization
Asai hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Asai hospital
Address
178-1 Yakata-cho, Seto, Aichi
Tel
0561843111
kowa_ahp.mgr@gctv.ne.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2016 | Year | 06 | Month | 01 | Day |
Date of IRB
| 2018 | Year | 10 | Month | 01 | Day |
Anticipated trial start date
| 2016 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2028 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Most appropriate treatment for uveitis patients is considered depending on the observational results of this screening
Management information
Registered date
| 2018 | Year | 05 | Month | 06 | Day |
Last modified on
| 2024 | Year | 05 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037037
